🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I am more than delighted, that Lizza has been nominated! She has done an outstanding work in motivating young colleagues, doing fantastic research and being one of our rising leaders in Thoracic Oncology!

Thanks for a wonderful invitation to an amazing meeting! Argentina rocks!😀

AI algorithm identifies higher PD-L1 expression cases in early-stage NSCLC than traditional pathology which could lead to improved patient selection for atezolizumab. Full interview with Prof Martin Reck of The DZL Academy 👉 tinyurl.com/ypvscteb Martin Reck #ELCC25

Advances in ctDNA assays enhance early relapse detection in lung cancer — sessions at #ASCO25 will showcase these data and I look forward to seeing the updates on MRD! Penn Medicine MD Penn Medicine Penn Medicine - Abramson Cancer Center ASCO OncoAlert Martin Reck

Would we have envisioned these Survival in non oncogenic driven NSCL 15 years ago? Grateful to see this for our patients!

Putting Pacific into real world conditions, another important piece of information. Thank you for the invitation!

Looking forward to seeing you at the poster and to discuss the data!😀

Ready for the IMforte Presentation at ASCO 2025! Thank you for an outstanding cooperation and Team! ASCO #LCSM

Dr. Martin Reck presents an exploratory analyses from AEGEAN of high-risk pts who may have reduced benefit with IO. Potential association here of KMT2C and KEAP1 mt for MRD @asco #ASCO25 #lcsm #lcam

🆕 #ASCO25 🆙 ☑️#LCSM Rapid Oral, LocReg/SCLC 🔥AEGEAN: Association of post-surgical MRD status with neoadj ctDNA dynamics, genomic mutations, and clinical outcomes 🎙️ Martin Reck 🎯No MRD-positive pts in the D arm had pCR or MPR OncoAlert ASCO LARVOL meetings.asco.org/2025-asco-annu…

Lung 🫁 rocks! Thank you for an amazing „Lung Cancer Family“ from all over the world and Marina Garassino for her outstanding hospitality! #LCSM

Just presented ASCO and published in The Lancet . Thank for the honor to be part of this important trial! #lcsm Efficacy and safety of first-line maintenance therapy with lurbinected... sciencedirect.com/science/articl…

Grateful to be part of this important project led by Marina Garassino arsela prelaj !

Herzliche Einladung! Ich freue mich auf eine lebhafte Diskussion!

Missed ASCO? Get the key insights now – fast & free 👉 high5oncologyTV: high5oncology.tv/meeting-covera… Stephen V Liu, MD Dr Riyaz Shah Frank Griesinger Martin Reck Noemi Reguart Lizza Hendriks Nicolas Girard denis Moro-Sibilot Hossein Borghaei, DO joaquim bellmunt Anders Bjartell Simon C Ignacio Duran

🔄 #ASCO25 REVIEW🔁 ☑️#LCSM Rapid Oral, LocReg/SCLC 🔥AEGEAN: Association of post-surgical MRD status with neoadj ctDNA dynamics, genomic muts, and outcomes 🎙️ Martin Reck 🎯No MRD-positive pts in the D arm had pCR or MPR OncoAlert ASCO LARVOL meetings.asco.org/2025-asco-annu…

I am truly humbled by the trust of ESMO members. Thank you all for your support! and warm congratulations to all my colleagues Martin, Nicoletta, Ulrik, and Hope, Martin Reck Ulrik Lassen Hope Rugo Eager to start walking this path together to shape the future of our Society ESMO - Eur. Oncology

Thank you for the privilege to be part of this exciting project!

Noemi Reguart Martin Reck Ulrik Lassen Hope Rugo ESMO - Eur. Oncology Congratulations - so well deserved Noemi!!

Thank you for your outstanding hospitality!